RMOC Recommendation: Standardising strengths of high risk, unlicensed oral liquids formulations for anti-TB medicines
9 April 2018At the meeting on 26th October 2017 the Regional Medicines Optimisation Committee (North) endorsed the approach put forward by the NHS Pharmaceutical Quality Assurance Committee…
Medicine Compliance Aid Stability
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture
31 July 2015